Total, unbound, renal, and hepatic clearances of raltegravir and the formation and elimination clearances of raltegravir glucuronide in pregnant Women (2023)
- Authors:
- USP affiliated authors: PEREIRA, MARIA PAULA MARQUES - FCFRP ; ROCHA, ADRIANA - FCFRP ; DUARTE, GERALDO - FMRP ; LANCHOTE, VERA LUCIA - FCFRP ; THOMAZ, MATHEUS DE LUCCA - FCFRP
- Unidades: FCFRP; FMRP
- DOI: 10.1002/jcph.2287
- Subjects: FARMACOCINÉTICA; INFECÇÕES POR HIV; FARMACOTERAPIA; GRAVIDEZ
- Keywords: Biliary excretion; Elimination pathway; Pharmacokinetics; Uridine 5 diphospho-glucuronosyltransferase
- Language: Inglês
- Imprenta:
- Source:
- Título: The Journal of Clinical Pharmacology
- ISSN: 0091-2700
- Volume/Número/Paginação/Ano: v. 63, n. 9, p. 1053-1060, 2023
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
MOREIRA, Fernanda de Lima et al. Total, unbound, renal, and hepatic clearances of raltegravir and the formation and elimination clearances of raltegravir glucuronide in pregnant Women. The Journal of Clinical Pharmacology, v. 63, n. 9, p. 1053-1060, 2023Tradução . . Disponível em: https://doi.org/10.1002/jcph.2287. Acesso em: 27 dez. 2025. -
APA
Moreira, F. de L., Paz, T. A., Melli, P. P. dos S., Thomaz, M. de L., Marques, M. P., Rocha, A., et al. (2023). Total, unbound, renal, and hepatic clearances of raltegravir and the formation and elimination clearances of raltegravir glucuronide in pregnant Women. The Journal of Clinical Pharmacology, 63( 9), 1053-1060. doi:10.1002/jcph.2287 -
NLM
Moreira F de L, Paz TA, Melli PP dos S, Thomaz M de L, Marques MP, Rocha A, Duarte G, Lanchote VL. Total, unbound, renal, and hepatic clearances of raltegravir and the formation and elimination clearances of raltegravir glucuronide in pregnant Women [Internet]. The Journal of Clinical Pharmacology. 2023 ; 63( 9): 1053-1060.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1002/jcph.2287 -
Vancouver
Moreira F de L, Paz TA, Melli PP dos S, Thomaz M de L, Marques MP, Rocha A, Duarte G, Lanchote VL. Total, unbound, renal, and hepatic clearances of raltegravir and the formation and elimination clearances of raltegravir glucuronide in pregnant Women [Internet]. The Journal of Clinical Pharmacology. 2023 ; 63( 9): 1053-1060.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1002/jcph.2287 - Detection of allopurinol and oxypurinol in canine urine by HPLC/MS-MS: focus on veterinary clinical pharmacokinetics
- Simultaneous analysis of the total plasma concentration of atorvastatin and its five metabolites and the unbound plasma concentration of atorvastatin: application in a clinical pharmacokinetic study of single oral dose
- Effect of chronic hepatitis C on the activity of the membrane transporters P‐gp and OATP1B1/BCRP on patients with different stages of hepatic fibrosis
- Suppression of CYP isoforms in patients with chronic hepatitis c before and after pharmacological treatment depends on the stage of hepatic fibrosis
- Optimizing therapeutic drug monitoring in pregnant women: a critical literature review
- P-Glycoprotein and organic anion transporter polypeptide 1B/breast cancer resistance protein drug transporter activity in pregnant women living with HIV
- Influence of gasoline inhalation on the enantioselective pharmacokinetics of fluoxetine in rats
- Analysis of ibuprofen enantiomers in rat plasma by liquid chromatography with tandem mass spectrometry
- Impact of Plasmodium vivax malaria and antimalarial treatment on cytochrome P450 activity in Brazilian patients
- Determination of raltegravir and raltegravir glucuronide in human plasma and urine by LC-MS/MS with application in a maternal-fetal pharmacokinetic study
Informações sobre o DOI: 10.1002/jcph.2287 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003257045.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
